CATALANO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.573
EU - Europa 1.269
AS - Asia 486
OC - Oceania 54
SA - Sud America 6
AF - Africa 4
Totale 3.392
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.569
RU - Federazione Russa 732
IT - Italia 225
SG - Singapore 145
HK - Hong Kong 133
IE - Irlanda 119
CN - Cina 77
AU - Australia 54
SE - Svezia 45
ID - Indonesia 42
IN - India 41
JO - Giordania 40
FR - Francia 29
FI - Finlandia 28
DE - Germania 24
AT - Austria 15
CH - Svizzera 15
NL - Olanda 14
GB - Regno Unito 8
BR - Brasile 5
BE - Belgio 4
CA - Canada 4
ES - Italia 3
JP - Giappone 3
CI - Costa d'Avorio 2
LT - Lituania 2
RS - Serbia 2
TN - Tunisia 2
TR - Turchia 2
CZ - Repubblica Ceca 1
EC - Ecuador 1
HR - Croazia 1
KR - Corea 1
LK - Sri Lanka 1
NO - Norvegia 1
UA - Ucraina 1
VN - Vietnam 1
Totale 3.392
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.016
Singapore 126
Dublin 117
Hong Kong 99
Ashburn 59
Florence 54
Melbourne 53
Chandler 51
Moscow 42
Jakarta 41
Shanghai 28
Helsinki 25
Mumbai 21
Bremen 17
Rome 17
Arezzo 15
Bern 15
Altamura 14
Kent 14
Lawrence 14
Vienna 14
Fairfield 13
Paris 10
Seattle 9
Wilmington 9
Los Angeles 8
New York 8
Princeton 8
Beijing 7
Boston 7
Decatur 7
Milan 7
Pune 7
Woodbridge 7
West Jordan 6
Yubileyny 6
Ann Arbor 5
Boardman 5
Cambridge 5
Houston 5
Prato 5
Washington 5
Brussels 4
Fontebuona 4
Grottammare 4
Ladispoli 3
Lappeenranta 3
Livorno 3
Medford 3
Romola 3
San Diego 3
São Paulo 3
Abidjan 2
Aix-en-Provence 2
Aryanah 2
Azusawa 2
Barberino di Mugello 2
Bologna 2
Casier 2
Cernusco sul Naviglio 2
Enna 2
Falls Church 2
Fucecchio 2
Grosseto 2
Hillsboro 2
Jaraguá do Sul 2
Kraljevo 2
London 2
Madrid 2
Modena 2
Padova 2
Pescara 2
Shenzhen 2
Venice 2
Zibo 2
Almè 1
Baoding 1
Bientina 1
Brossard 1
Buffalo 1
Capannoli 1
Cascina 1
Chennai 1
Chiesina Uzzanese 1
Clifton 1
Colombo 1
Council Bluffs 1
Dongguan 1
Guayaquil 1
Huntington Beach 1
Kilburn 1
Leawood 1
Manhasset 1
Munich 1
Nanning 1
Newark 1
Nuremberg 1
Oslo 1
Ottawa 1
Pingdingshan 1
Totale 2.105
Salva come PNG Salva come JPEG
Nome #
Germline mutations in MSH2 and ATM gene in patients with GIST (gastrointestinal stromal tumor) and second epitelial tumors 105
A case report of a lung cancer patient with two uncommon EGFR mutations and a review of the literature: two sides of the same coin 100
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 99
Inflammation in Urological Malignancies: The Silent Killer 97
Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study 97
Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand? 89
Immune checkpoint inhibitor-induced neurologic toxicity: a case report and literature review 84
Gastric and colonic metastasis from NSCLC A very unusual case report 84
Correlation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy 82
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer 81
Current status and future perspectives in HER2 positive advanced gastric cancer 76
Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy 76
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice 76
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? 75
Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors 73
Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinoma 73
Systemic Sclerosis Association with Malignancy 72
The gut microbiome and efficacy of cancer immunotherapy 70
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors 68
DNA repair deficiency as circulating biomarker in prostate cancer 62
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities? 62
Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment 61
Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients 60
Second line of treatment for HER2-positive gastric cancer: an evolving issue 60
Liquid biopsy in colorectal cancer: No longer young, but not yet old 60
Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope? 58
Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge 57
Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments 53
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 52
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma 49
Editorial: Analysis of tumor immune microenvironments and molecular mechanism to reveal the dilemma of immunotherapy for advanced non-small cell lung cancer 48
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next 48
Reconceiving Perineural Invasion in Cutaneous Squamous Cell Carcinoma: From Biological to Histopathological Assessment 48
Management Approaches for High-Risk Cutaneous Squamous Cell Carcinoma with Perineural Invasion: An Updated Review 47
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials 46
Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas 46
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study 45
FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer 44
Capecitabine as a Second-line Treatment for Older Patients with Pancreatic Cancer 43
Editorial: Microbiota and metabolites in cancer immunotherapy 42
Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers 42
Tyrosine kinase and immune checkpoints inhibitors in favorable risk metastatic renal cell carcinoma: Trick or treat? 40
Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis-what is currently known? 39
The evolving treatment landscape of metastatic urothelial cancer 38
First-Line Treatments and Management of Metastatic Renal Cell Carcinoma Patients: An Italian Interdisciplinary Uro-Oncologic Group Algorithm 37
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study 37
Cancer management during the COVID-19 world pandemic 37
The latest developments in biomarkers predicting response to immunotherapy 35
Immunotherapy-related biomarkers: Confirmations and uncertainties 35
Front-Line Therapeutic Strategy in Metastatic Hormone Sensitive Prostate Cancer: An Updated Therapeutic Algorithm 35
Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually? 34
Rechallenge of immune checkpoint inhibitors: A systematic review and meta-analysis 33
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab 32
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib 32
Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer 32
Risk Factors for Nab-Paclitaxel and Gemcitabine-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer 30
Personalized medicine for metastatic prostate cancer: The paradigm of PARP inhibitors 30
The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer 29
Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma 28
Immune combinations and complete response: a new hope for metastatic renal cell carcinoma 27
Prognostic value of alkaline phosphatase and gamma-glutamyl transferase in patients with metastatic pancreatic cancer 26
Tumor microenvironment in renal cell carcinoma: what is the current impact? 25
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study 21
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1) 16
Antiangiogenic drugs as chemosensitizer in genitourinary cancer 14
Antiangiogenic drugs as chemosensitizer in renal cell cancer 7
Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine 6
Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors 6
Totale 3.471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 5 0 0 12 2 8 3 2 2
2021/202262 2 0 0 0 0 8 0 22 3 2 3 22
2022/2023429 10 44 6 37 15 68 97 37 53 18 16 28
2023/2024528 13 34 50 21 31 65 26 116 18 49 48 57
2024/20252.418 128 319 130 453 925 462 1 0 0 0 0 0
Totale 3.471